Richard Look

419 total citations
14 papers, 358 citations indexed

About

Richard Look is a scholar working on Social Psychology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard Look has authored 14 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Social Psychology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard Look's work include Neuroendocrine regulation and behavior (8 papers), Electrolyte and hormonal disorders (6 papers) and Receptor Mechanisms and Signaling (4 papers). Richard Look is often cited by papers focused on Neuroendocrine regulation and behavior (8 papers), Electrolyte and hormonal disorders (6 papers) and Receptor Mechanisms and Signaling (4 papers). Richard Look collaborates with scholars based in United States and Germany. Richard Look's co-authors include Keith T. Demarest, Barbara R. Conway, Bruce E. Maryanoff, Philip J. Rybczynski, Patricia Andrade‐Gordon, John B. Moore, Joseph W. Gunnet, Yong‐Zheng Zhang, Han‐Cheng Zhang and Yin Liang and has published in prestigious journals such as Bioorganic & Medicinal Chemistry Letters, Scandinavian Journal of Gastroenterology and Clinical and Experimental Pharmacology and Physiology.

In The Last Decade

Richard Look

14 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Look United States	10	181	158	42	41	33	14	358
Shirley M. Williams United States	10	102 0.6×	145 0.9×	11 0.3×	18 0.4×	18 0.5×	18	379
Andrew Payne United Kingdom	11	76 0.4×	151 1.0×	9 0.2×	31 0.8×	10 0.3×	22	408
Yasuyoshi Arikawa Japan	12	448 2.5×	204 1.3×	5 0.1×	7 0.2×	95 2.9×	23	843
Lu Xiao China	11	40 0.2×	130 0.8×	8 0.2×	33 0.8×	23 0.7×	33	324
G Grosu United States	10	222 1.2×	119 0.8×	17 0.4×	10 0.2×	16 0.5×	19	342
Argyrios G. Arvanitis United States	9	200 1.1×	110 0.7×	10 0.2×	25 0.6×	12 0.4×	15	390
Dina Baier Austria	14	93 0.5×	117 0.7×	5 0.1×	12 0.3×	25 0.8×	28	358
Yasutaka Takase Japan	10	283 1.6×	250 1.6×	5 0.1×	8 0.2×	19 0.6×	17	546
V.P. Gerskowitch United Kingdom	14	67 0.4×	178 1.1×	10 0.2×	3 0.1×	16 0.5×	29	426
Robert J. Altenbach United States	15	239 1.3×	235 1.5×	2 0.0×	30 0.7×	5 0.2×	27	533

Countries citing papers authored by Richard Look

Since Specialization

Citations

This map shows the geographic impact of Richard Look's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Look with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Look more than expected).

Fields of papers citing papers by Richard Look

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Look. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Look. The network helps show where Richard Look may publish in the future.

Co-authorship network of co-authors of Richard Look

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Look. A scholar is included among the top collaborators of Richard Look based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Look. Richard Look is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rybczynski, Philip J., Mona Patel, Robert H. Chen, et al.. (2007). Next-generation spirobenzazepines: Identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies. Bioorganic & Medicinal Chemistry Letters. 17(23). 6623–6628. 12 indexed citations

Gunnet, Joseph W., Jay M. Matthews, Bruce E. Maryanoff, et al.. (2006). CHARACTERIZATION OF RWJ‐351647, A NOVEL NONPEPTIDE VASOPRESSIN V₂RECEPTOR ANTAGONIST. Clinical and Experimental Pharmacology and Physiology. 33(4). 320–326. 8 indexed citations

Zhang, Yong‐Zheng, John B. Moore, Richard Look, et al.. (2006). Synthesis and Evaluation of 3‐Anilino‐quinoxalinones as Glycogen Phosphorylase Inhibitors.. ChemInform. 37(5). 1 indexed citations

Zhang, Yong‐Zheng, John B. Moore, Richard Look, et al.. (2005). Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(21). 4790–4793. 69 indexed citations

Matthews, Jay M., Dennis J. Hlasta, Patricia Andrade‐Gordon, et al.. (2005). Pyrazinobenzodiazepines as Potent Nonpeptide Vasopressin Receptor Antagonists. Letters in Drug Design & Discovery. 2(3). 219–223. 5 indexed citations

Chen, Robert H., Keith T. Demarest, Joseph W. Gunnet, et al.. (2004). Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists. Bioorganic & Medicinal Chemistry Letters. 14(12). 3143–3146. 4 indexed citations

Zhang, Han‐Cheng, Hong Ye, Barbara R. Conway, et al.. (2004). 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3. Bioorganic & Medicinal Chemistry Letters. 14(12). 3245–3250. 57 indexed citations

Chen, Robert H., Keith T. Demarest, Joseph W. Gunnet, et al.. (2004). Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(11). 2987–2989. 10 indexed citations

Matthews, Jay M., William J. Hoekstra, Alexey B. Dyatkin, et al.. (2004). Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templates. Bioorganic & Medicinal Chemistry Letters. 14(11). 2747–2752. 17 indexed citations

10.

Chen, Robert H., Keith T. Demarest, Joseph W. Gunnet, et al.. (2003). 2,5-Disubstituted 3,4-dihydro-2H-benzo[b][1,4]thiazepines as potent and selective V2 arginine vasopressin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(22). 4031–4034. 32 indexed citations

11.

Zhang, Han‐Cheng, Hong Ye, David F. McComsey, et al.. (2003). Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3. Bioorganic & Medicinal Chemistry Letters. 13(18). 3049–3053. 52 indexed citations

12.

Matthews, Jay M., Michael N. Greco, Leonard R. Hecker, et al.. (2003). Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(4). 753–756. 30 indexed citations

13.

Dyatkin, Alexey B., William J. Hoekstra, Dennis J. Hlasta, et al.. (2002). Bridged bicyclic vasopressin receptor antagonists with V2-Selective or dual V1a/V2 activity. Bioorganic & Medicinal Chemistry Letters. 12(21). 3081–3084. 10 indexed citations

14.

Look, Richard. (2000). Is the Increase in Serum Cystathionine Levels in Patients with Liver Cirrhosis a Consequence of Impaired Homocysteine Transsulfuration at the Level of ?-Cystathionase?. Scandinavian Journal of Gastroenterology. 35(8). 866–872. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact